Home Cart 0 Sign in  
X

[ CAS No. 4786-52-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 4786-52-1
Chemical Structure| 4786-52-1
Chemical Structure| 4786-52-1
Structure of 4786-52-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 4786-52-1 ]

Related Doc. of [ 4786-52-1 ]

Alternatived Products of [ 4786-52-1 ]

Product Details of [ 4786-52-1 ]

CAS No. :4786-52-1 MDL No. :MFCD00194922
Formula : C7H8N2O3 Boiling Point : -
Linear Structure Formula :- InChI Key :PLMIZYMXBHSARX-UHFFFAOYSA-N
M.W : 168.15 Pubchem ID :96347
Synonyms :

Calculated chemistry of [ 4786-52-1 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.29
Num. rotatable bonds : 3
Num. H-bond acceptors : 4.0
Num. H-bond donors : 1.0
Molar Refractivity : 40.94
TPSA : 72.05 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.52 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.06
Log Po/w (XLOGP3) : -0.28
Log Po/w (WLOGP) : -0.05
Log Po/w (MLOGP) : -0.22
Log Po/w (SILICOS-IT) : 1.18
Consensus Log Po/w : 0.34

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.88
Solubility : 22.3 mg/ml ; 0.132 mol/l
Class : Very soluble
Log S (Ali) : -0.77
Solubility : 28.3 mg/ml ; 0.168 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.03
Solubility : 1.55 mg/ml ; 0.00925 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.69

Safety of [ 4786-52-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 4786-52-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 4786-52-1 ]
  • Downstream synthetic route of [ 4786-52-1 ]

[ 4786-52-1 ] Synthesis Path-Upstream   1~3

  • 1
  • [ 38026-46-9 ]
  • [ 4786-52-1 ]
  • [ 28485-17-8 ]
Reference: [1] Journal of the American Chemical Society, 1942, vol. 64, p. 794,797
  • 2
  • [ 4786-52-1 ]
  • [ 41103-17-7 ]
YieldReaction ConditionsOperation in experiment
99% With thionyl chloride In tetrahydrofuran for 4 h; Heating / reflux Ethyl 4-hydroxypyrimidine-5-carboxylate (380 mg, 2.26 mmol) was dissolved in THF (5 mL) and treated with thionyl chloride (1.65 ml, 22.6 mmol). The solution was heated to reflux for 4 h and then concentrated in vacuo, yielding 417 mg (99percent) of the crude product. This material was used without purification or characterization.
99% With thionyl chloride In tetrahydrofuran for 4 h; Heating / reflux Ethyl 4-hydroxypyπmιdιne-5-carboxylate (380 mg, 2.26 mmol) was dissolved in THF (5 mL) and treated with thionyl chloride (1.65 ml, 22.6 mmol). The solution was heated to reflux for 4 h and then concentrated in vacuo, yielding 417 mg (99percent) of the crude product This material was used without purification or characterization
99% With thionyl chloride In tetrahydrofuran for 4 h; Heating / reflux Ethyl 4-hydroxypyrimidine-5-carboxylate (380 mg, 2.26 mmol) was dissolved in THF (5 mL) and treated with thionyl chloride (1.65 ml, 22.6 mmol). The solution was heated to reflux for 4 h and then concentrated in vacuo, yielding 417 mg (99percent) of the crude product. This material was used without purification or characterization.
95% at 120℃; for 5 h; 2 g of the compound obtained in step 1) above was dissolved in 3.5 mL of phosphorus oxychloride, and 18 mL of thionylchloride and 50 \\ih of dimethylformamide were added thereto. The mixture was stirred at 120°C under reflux for 5 hours. After the reaction was completed, the reaction mixture was distilled under a reduced pressure. 50 mL of toluene was added to the residue, the resulting residue was distilled under a reduced pressure (repeated twice) and the resulting solid was dried to obtain the title compound (2.1 g, yield: 95percent).1H-NMR (300MHz, DMSO-d6) δ 9.18 (s, 2H), 4.36 {dd, 2H), 1.33 (t, 3H).
77% With N-ethyl-N,N-diisopropylamine; trichlorophosphate In toluene at 70℃; for 2 h; To a suspension of ethyl 4-hydroxy-pyrimidine-5-carboxylate (3.0g, 17.6 mmol) in toluene (35ml) was added diisopropylethylamine (3.4 ml, 19.6mmol) and phosphorous oxychloride (1.8 ml, 19.6 mmol) dropwise under a nitrogen atmosphere. The reaction mixture was heated to 700C, and stirred for two hours then cooled to 5°C. A IM aqueous solution of sodium hydroxide (26 ml) was added and the mixture was diluted with water and extracted into ethyl acetate. The organic layer was washed with water, saturated sodium hydrogencarbonate, then dried over sodium sulfate, filtered and concentrated to give the title compound as a brown oil (2.56g, 77percent). 1H NMR (CDCl3, 400 MHz) 9.13 (s, IH), 9.08 (s, IH), 4.47 (q, J = 6.9 Hz, 2H), 1.44 (t, J = 6.9 Hz, 3H).

Reference: [1] Patent: WO2006/91506, 2006, A2, . Location in patent: Page/Page column 40
[2] Patent: WO2006/49681, 2006, A2, . Location in patent: Page/Page column 38
[3] Patent: WO2006/121588, 2006, A2, . Location in patent: Page/Page column 44
[4] Patent: WO2006/121860, 2006, A2, . Location in patent: Page/Page column 44
[5] Patent: WO2006/121904, 2006, A1, . Location in patent: Page/Page column 44
[6] Patent: WO2011/99764, 2011, A2, . Location in patent: Page/Page column 36
[7] Patent: WO2008/24725, 2008, A1, . Location in patent: Page/Page column 79
[8] Journal of Medicinal Chemistry, 2012, vol. 55, # 23, p. 10475 - 10489
  • 3
  • [ 4786-52-1 ]
  • [ 41103-17-7 ]
Reference: [1] Patent: US5500427, 1996, A,
[2] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 21, p. 6756 - 6761
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 4786-52-1 ]

Amides

Chemical Structure| 65754-04-3

[ 65754-04-3 ]

6-Oxo-1,6-dihydropyrimidine-5-carboxylic acid

Similarity: 0.92

Chemical Structure| 67383-32-8

[ 67383-32-8 ]

Ethyl 4-hydroxy-2-methylpyrimidine-5-carboxylate

Similarity: 0.91

Chemical Structure| 53554-29-3

[ 53554-29-3 ]

Ethyl 2-(methylthio)-6-oxo-1,6-dihydropyrimidine-5-carboxylate

Similarity: 0.79

Chemical Structure| 313535-84-1

[ 313535-84-1 ]

Methyl 4-oxo-3,4-dihydroquinazoline-7-carboxylate

Similarity: 0.68

Chemical Structure| 155960-91-1

[ 155960-91-1 ]

Ethyl 3,4-dihydro-4-oxoquinazoline-6-carboxylate

Similarity: 0.65

Esters

Chemical Structure| 67383-32-8

[ 67383-32-8 ]

Ethyl 4-hydroxy-2-methylpyrimidine-5-carboxylate

Similarity: 0.91

Chemical Structure| 53554-29-3

[ 53554-29-3 ]

Ethyl 2-(methylthio)-6-oxo-1,6-dihydropyrimidine-5-carboxylate

Similarity: 0.79

Chemical Structure| 313535-84-1

[ 313535-84-1 ]

Methyl 4-oxo-3,4-dihydroquinazoline-7-carboxylate

Similarity: 0.68

Chemical Structure| 155960-91-1

[ 155960-91-1 ]

Ethyl 3,4-dihydro-4-oxoquinazoline-6-carboxylate

Similarity: 0.65

Chemical Structure| 42821-92-1

[ 42821-92-1 ]

Methyl 2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate

Similarity: 0.63

Related Parent Nucleus of
[ 4786-52-1 ]

Pyrimidines

Chemical Structure| 65754-04-3

[ 65754-04-3 ]

6-Oxo-1,6-dihydropyrimidine-5-carboxylic acid

Similarity: 0.92

Chemical Structure| 67383-32-8

[ 67383-32-8 ]

Ethyl 4-hydroxy-2-methylpyrimidine-5-carboxylate

Similarity: 0.91

Chemical Structure| 53554-29-3

[ 53554-29-3 ]

Ethyl 2-(methylthio)-6-oxo-1,6-dihydropyrimidine-5-carboxylate

Similarity: 0.79

Chemical Structure| 42821-92-1

[ 42821-92-1 ]

Methyl 2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate

Similarity: 0.63

Chemical Structure| 65195-35-9

[ 65195-35-9 ]

Ethyl 4-aminopyrimidine-5-carboxylate

Similarity: 0.61